SCHEMBL5899480

SCHEMBL5899480

Cc1cc(C)cc(S(=O)(=O)NCC(=O)c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 5/20 0.54
RECQL P46063 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEP1B Q16820 1/20 0.46
MMP1 P03956 1/20 0.45
GAA P10253 1/20 0.45
MMP12 P39900 1/20 0.45
ACLY P53396 1/20 0.45
USP2 O75604 1/20 0.45
HSD11B1 P28845 1/20 0.44
AKR1C3 P42330 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899429 0.88 KAT6A (0.68) KAT6AKMT2AALDH1A1MEP1BAKR1C3
SCHEMBL5320466 0.86 ALDH1A1 (0.60) KAT6ARECQLKMT2AMEN1NPC1
SCHEMBL5899491 0.85 KAT6A (0.62) KAT6ANPC1RAB9AALDH1A1GAA
SCHEMBL5899544 0.84 KAT6A (0.58) KAT6AKMT2AMEN1ALDH1A1MEP1B
SCHEMBL28531984 0.78 ALDH1A1 (0.58) KAT6AKMT2AMEN1ALDH1A1NPSR1
SCHEMBL23014361 0.77 KAT6A (0.58) KAT6AKMT2AMEN1ALDH1A1MEP1B
SCHEMBL5899482 0.77 L3MBTL1 (0.60) KAT6AKMT2AMEN1ALDH1A1MEP1B
SCHEMBL5899737 0.77 MMP1 (0.63) KAT6AKMT2AMEN1ALDH1A1MEP1B
SCHEMBL5320463 0.77 ITGAV (0.51) KAT6AKMT2AMEN1NPC1RAB9A
SCHEMBL754844 0.77 KMT2A (0.56) KAT6ARECQLKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885RECQL 3378/4885KMT2A 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.